GLP-1 Weight Care
Tirzepatide
A dual-agonist GLP-1 / GIP program for patients seeking advanced metabolic results under provider direction, with flat-rate pricing.
Available by consultation
Clinical Overview
How Tirzepatide works
The first medication in its class to engage two metabolic pathways at once — and the reason its trial outcomes set a new ceiling.
Engages the GIP receptor
Targets glucose-dependent insulinotropic polypeptide — a metabolic pathway most weight medications do not address.
Engages the GLP-1 receptor
Simultaneously mimics GLP-1 — easing appetite and slowing how quickly food leaves the stomach.
Combined metabolic effect
The dual mechanism produces the highest average weight loss recorded in any GLP-1-class clinical trial to date.
Candidacy Profiling
A considered fit, not a funnel.
Adults seeking the most advanced GLP-1-class program, with the supervision and titration discipline this medication calls for.
- Adults 18+ with a BMI of 27 or higher, or 25+ with weight-related conditions
- People who have plateaued on a single-agonist GLP-1 and want to escalate under supervision
- Anyone for whom faster onset and higher trial averages are clinically appropriate
- Personal or family history of medullary thyroid carcinoma or MEN 2
- Pregnancy, breastfeeding, or planning pregnancy
- Active pancreatitis or untreated severe gastrointestinal disease
Expected Timeline
What to Expect
Tirzepatide tends to act faster and reach further than single-agonist GLP-1s. Your provider titrates carefully to the dose that fits your body.
- 01
Month 1
Titration
Faster initial response than single-agonist GLP-1s. Careful dose escalation begins.
- 02
Month 3
Established
Therapeutic dose reached. Strong metabolic momentum; appetite consistently reduced.
- 03
Month 6
~20%
Average body weight reduction in published trials. Many patients exceed this range.
- 04
Year 1+
Sustained
Sustained reduction for the majority of patients who remain in the program.
Outcomes referenced from SURMOUNT-1 trial data. Individual results depend on starting weight, dose, and adherence.
Your Concierge Support
A licensed clinician, matched to you.
Vela is powered by independent, U.S.-licensed providers and a dedicated care team focused on GLP-1 weight care and NAD⁺ therapy. Every patient receives licensed clinical review and direct, secure messaging on your schedule — quiet, respectful care that stays with you through every step of the journey.
- 01Compounded medication
- Prepared by partner compounding pharmacies and shipped on a structured cadence.
- 02A dedicated provider
- Every interaction is guided directly by a licensed provider — not a rotating call center.
- 03Provider-directed dosing
- Titration and adjustments at every transition, under clinical supervision.
- 04Direct message access
- Reach your provider between scheduled check-ins through your secure patient portal.
- 05Structured check-ins
- Cadenced reviews that keep your protocol calibrated to how you respond.
- 06Discreet delivery
- Temperature-controlled, unmarked packaging delivered direct to your door.
The Vela Standard
Real progress, made quietly — and made right.
- 01.Evidence first
- Every plan is grounded in the clinical literature and reviewed by a licensed provider. No hype, no guesswork — just what the science supports for you.
- 02.Discreet by design
- Private intake, secure messaging, and unmarked, tracked delivery. Your care is yours alone — no waiting rooms, no shame, no noise.
- 03.Guided the whole way
- You are never handed a prescription and left alone. Your provider titrates, checks in, and adjusts as your body responds — start to goal and beyond.
Clinical Safety
No medication is right for everyone.
Common side effects
Most common during titration: nausea, decreased appetite, and digestive changes. Typically mild and resolve as the body adjusts to each step in the protocol.
Clinical Contraindications
Not appropriate for patients with a personal or family history of medullary thyroid carcinoma or MEN 2, or for patients who are pregnant or breastfeeding. Full medical history is reviewed before any prescription is authorized.
Vela Rx programs are prepared by partner compounding pharmacies in the United States. Compounding pharmacies are regulated by both state boards and the FDA and have been part of American medicine since long before mass-manufactured drugs existed. The active ingredient is prepared per your protocol — supervised by your provider — and delivered direct to your door.
Clinical Experience
From members of the Tirzepatide program.
- “
I had done six months on Semaglutide and plateaued. The switch to Tirzepatide was a second wind. I am down another twenty-two pounds in four months and feel like myself again.
- “
Honestly the speed surprised me. By week three I had to set reminders to eat — that had never been my problem. My energy is up and my labs are better than they have been in a decade.
- “
I was skeptical the higher cost was worth it. After comparing my own progress to friends on Semaglutide, my answer was yes. My provider helped me think it through honestly.
Frequently Asked
Questions worth asking before you begin.
Every program begins with a secure online consultation. If your provider authorizes treatment, your protocol is prepared by a partner compounding pharmacy and delivered discreetly to your door, with structured check-ins and direct messaging access to your provider throughout.
We believe in complete transparency. Our programs use flat-rate pricing with no hidden fees, no consultation charges, and no dose-change surcharges. The price we quote is the price you pay.
Vela Rx operates via telehealth across the states where we are able to serve patients.
Your consultation is reviewed and authorized by an independent, licensed provider. Every patient receives consistent, licensed clinical care with direct messaging access.
Memberships may be canceled with 30 days' notice prior to the next billing cycle. Consultations, medical visits, and fulfilled prescriptions are non-refundable once services begin or medication is processed.
Yes. Vela Rx is HIPAA compliant. Your medical information is shared only with your assigned provider and the dispensing pharmacy. We never sell or share your data.
Comparison Protocol
Semaglutide
The foundational single-agonist GLP-1 program. Lower trial averages, often the right starting point.
Begin Consultation
The Tirzepatide program begins with a conversation.
Your consultation is reviewed by your dedicated provider. If authorized, your protocol is prepared by a partner compounding pharmacy and delivered direct to your door.